Abstract
In this issue of Blood, Mascarenhas et al report on the safety and efficacy of oral idasanutlin in high-risk patients with polycythemia vera [PV]) wit......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
